ADAR1 Capital Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Buy |
+28,415
| New | +$106K | 0.02% | 165 |
|
|
2024
Q4 | – | Sell |
-24,702
| Closed | -$206K | – | 276 |
|
|
2024
Q3 | $206K | Buy |
24,702
+9,702
| +65% | +$80.9K | 0.03% | 152 |
|
|
2024
Q2 | $102K | Buy |
15,000
+10,000
| +200% | +$68.1K | 0.02% | 157 |
|
|
2024
Q1 | $32.8K | Sell |
5,000
-8,007
| -62% | -$52.5K | 0.01% | 184 |
|
|
2023
Q4 | $84.4K | Buy |
+13,007
| New | +$84.4K | 0.03% | 89 |
|